← Eichor
Condition: Ald Alcoholic Liver Disease Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Ald Alcoholic Liver Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

French National MICMAF Cohort
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05895890Evaluating Alcohol Use in Alcoholic Liver Disease
Phase N/A · 1 location(s) · Nicole T Shen · NCT03267069In Patients With Chronic Liver Diseases(Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease), LAENNEC(Human Pl
Phase 3 · 1 location(s) · Green Cross Wellbeing · NCT06493799Health Literacy and Self-efficacy Expectations in Patients With Alcohol-related Liver Cirrhosis
Phase N/A · 1 location(s) · Hannover Medical School · NCT07169526Effect of Fermented Protaetia Brevitarsis Seulensis Powder on Alcohol-induced Liver Disease
NA · 1 location(s) · Pusan National University Yangsan Hospital · NCT04320199Integrated Diagnostics for Early Diagnosis of Liver Disease
Phase N/A · 1 location(s) · Manchester University NHS Foundation Trust · NCT04666402Study of Alcohol-related Liver Disease in Europe
Phase N/A · 1 location(s) · University Hospital, Lille · NCT04400604Alcohol Misuse Treatment to Patients Newly Diagnosed With Alcohol-related Liver Disease: a Randomized Controlled Trial
NA · 1 location(s) · Zealand University Hospital · NCT06493773Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients
NA · 13 location(s) · University Hospital, Angers · NCT05699018Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers
NA · 1 location(s) · Maja Thiele · NCT03308916Study of Genetic Determinants in Alcoholic Hepatitis and Establishment of a Multicenter Prospective Cohort of Patients W
Phase N/A · 9 location(s) · University Hospital, Lille · NCT04106518The Liver Care Trial
NA · 2 location(s) · Zealand University Hospital · NCT05855031Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
Phase 3 · 84 location(s) · Bausch Health Americas, Inc. · NCT07428538Study of HMB-enriched Amino Acid Supplementation in Patients With Alcoholic Liver Disease and COVID-19
NA · 1 location(s) · The Cleveland Clinic · NCT04858412Identification of Hepatic Fibrosis Using 4D-MRI
NA · 2 location(s) · University Hospital, Basel, Switzerland · NCT05385237A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Y
Phase 2 · 131 location(s) · GlaxoSmithKline · NCT06613698HA35 Moderate Alcoholic Hepatitis (AH) Study
EARLY_Phase 1 · 1 location(s) · The Cleveland Clinic · NCT05018481Intra-Hepatic Microbiota in Alcoholic Hepatitis
Phase N/A · 1 location(s) · Hospices Civils de Lyon · NCT06307964Comparison of ALD, NASH, and Healthy Control Patients
Phase N/A · 1 location(s) · The Cleveland Clinic · NCT03224949Comparison of Inflammatory Profiles and Regenerative Potential in Alcoholic Liver Disease
NA · 1 location(s) · University Hospital, Lille · NCT03773887Ethanol Induces Skeletal Muscle Autophagy
Phase N/A · 1 location(s) · The Cleveland Clinic · NCT03209791A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis
Phase 3 · 23 location(s) · King's College London · NCT06461208
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.